global pandemic
Damage to int'l tourism in 2020 estimated at $1.3 trillion amid pandemic
Revenue loss in the international tourism sector in 2020 caused by a decrease in travelers crossing borders is estimated at $1.3 trillion, on the back of strict travel bans imposed by countries amid the coronavirus pandemic, a U.N. body said.
Russia’s Gamaleya center works on technology to quickly develop coronavirus vaccines
Russia’s Gamaleya National Research Center for Epidemiology and Microbiology works on the technology accelerating the creation of a novel coronavirus vaccine in case of rapid genomic alterations of the infectious agent, Alexander Gintsburg, the head of the Sputnik V vaccine center, said in a televised interview with Rossiya-1 news channel, an excerpt of which was aired on the channel on Friday.
Myanmar registers Russia’s Sputnik V COVID-19 vaccine
The Russian coronavirus vaccine Sputnik V has been registered in Myanmar, according to the Twitter account of Sputnik V.
Further discussion needed on use of AstraZeneca's COVID-19 vaccine for elderly: panel
A South Korean panel of experts has advised that vaccines for the novel coronavirus by AstraZeneca should be administered to people aged 65 or older following further discussion, according to the country's drug safety agency Friday.
Biden's dilemma in virus aid fight: Go big or go bipartisan
President Joe Biden’s push for a $1.9 trillion COVID-19 relief bill is forcing an internal reckoning that pits his instincts to work toward a bipartisan deal against the demands of an urgent crisis and his desire to deliver for those who helped elect him.
Russia’s Epivaccorona vaccine to provide immunity for up to a year, developer expects
Russia’s Epivaccorona vaccine will provide immunity against COVID-19 for approximately a year, the State Research Center of Virology and Biotechnology "Vector" informed.
Unwilling to wait, poorer countries seek their own vaccines
With coronavirus cases still climbing, Honduras got tired of waiting to get vaccines through a United Nations program, so the small Central American country struck out on its own, securing the shots through a private deal.
‘Eye of the storm’: Diverse east London grapples with virus
Taxicab driver Gary Nerden knows colleagues who got seriously ill from COVID-19. He knows the area of east London where he lives and works has among the highest infection rates in the whole of England. But since he can’t afford not to work, he drives around picking up strangers for up to 12 hours a day, relying on a flimsy plastic screen to keep him safe.
Study finds 'Oxford vaccine' may reduce virus transmission
AstraZeneca’s COVID-19 vaccine does more than prevent people from falling seriously ill — it appears to reduce transmission of the virus and offers strong protection for three months on just a single dose, researchers said Wednesday in an encouraging turn in the campaign to suppress the outbreak.
Oxford-AstraZeneca vaccine OK for all adults: S Korea panel
A South Korean panel of experts has said that vaccines for the novel coronavirus by AstraZeneca can be administered to elderly people amid efficacy controversies, according to the country's drug safety agency Monday.